Skip to content

Viatris VTRS Other Income (Expense)

Other Income (Expense) at other companies

McKesson logo
McKessonMCK
$36M
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$651K-429%
Cencora logo
CencoraCOR
$1.09B+30,738%
AMP
Amphastar PharmaceuticalsAMPH
-$3.58M+44.4%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
-$473K-115%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$61.6M+2.0%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$20.8B+92.8%
Enterprise value$33.61B+34.5%
P/S1.4×+0.7×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's other income (expense)?
Viatris (VTRS) reported other income (expense) of -$47.5M in Q1 2026.
How has Viatris's other income (expense) changed year-over-year?
Viatris's other income (expense) increased by 52.2% year-over-year, from -$99.3M to -$47.5M.
What is the long-term trend for Viatris's other income (expense)?
Over 3 years (2021 to 2025), Viatris's other income (expense) has grown at a 350.6% compound annual growth rate (CAGR), from $5.8M to -$530.6M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.